98%
921
2 minutes
20
This report highlights the rare progression of a dural arteriovenous fistula (dAVF) over four decades, evolving from an initially benign presentation to aggressive hemorrhagic features. A 58-year-old male presented with uncontrollable scalp bleeding secondary to a pulsating mass on the right temporal area. Diagnostic cerebral angiography revealed a complex right transverse sinus dAVF with multiple arterial feeders, primarily from the bilateral superficial temporal arteries (STA) and occipital arteries via the external carotid arteries (ECA). Internal carotid artery (ICA) injections failed to adequately opacify due to advanced atherosclerotic changes. No cortical venous reflux or venous ectasia was identified; instead, a serpiginous network of ECA feeders was observed, likely due to collateral development following a prior ligation in 1979. Clinically, the patient's only presenting complaint was persistent scalp hemorrhage from the vascular mass. He exhibited no neurological deficits preoperatively, and no steal phenomena or other typical dAVF-related symptoms were observed. The hemorrhage, initially manifesting as anemia, was managed conservatively with transfusions before definitive treatment. Surgical ligation of the ECA feeders was performed via an open technique. As this did not involve an endovascular embolization, no immediate postoperative angiogram was obtained. The patient showed significant clinical improvement and was discharged in a stable condition without any neurological deficits. This report underscores the importance of patient compliance, long-term follow-up, and timely neurosurgical intervention in managing progressive dAVFs, particularly those evolving over decades with atypical presentations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276635 | PMC |
http://dx.doi.org/10.7759/cureus.88348 | DOI Listing |
J Vasc Surg
September 2025
Division of Vascular Surgery, Stanford University School of Medicine, Stanford, CA.
Objective: Failure of arteriovenous fistula (AVF) maturation results in unnecessary patient risk and resource waste. We sought to identify potentially addressable risk factors for fistula failure-to-mature (FTM) to cannulation readiness.
Methods: We conducted a single-institution retrospective review of patients undergoing primary AVF creation from 2015-2021.
J Vasc Access
September 2025
Prince of Wales Hospital, Sydney, NSW, Australia.
Objective: Minimal Invasive Dialysis Access (MIDA) for renal dialysis encompasses percutaneous arteriovenous fistula (pAVF) creation and the modified percutaneous Seldinger peritoneal dialysis catheter insertions (pPD). This review examines the impact of MIDA on technical success, maturation rates, patency, clinical benefits, complications, and cost.
Methods: A review was made of the literature on MIDA including pAVF creation and pPD insertion regarding technical success rates, maturation rates, patency, clinical benefits, complications, and cost.
Khirurgiia (Mosk)
September 2025
Mandryka Central Military Clinical Hospital, Moscow, Russia.
Widespread fragmentation shells in combat operations with frequent multiple damage to organs and systems force to use all available diagnostic methods for treating severe injuries including lesion of great vessels of extremities. One of the consequences of these lesions is arteriovenous fistula (AVF). The last one may be asymptomatic at first.
View Article and Find Full Text PDFCardiovasc Interv Ther
September 2025
Department of Cardiovascular Medicine, Kyoto Chubu Medical Center, 25, Yagi-Ueno, Yagi-cho, Nantan, Kyoto, 629-0197, Japan.
Clin J Am Soc Nephrol
September 2025
Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL.
For many years, the vascular access guidelines recommended placement of arteriovenous fistulas (AVFs) in preference to arteriovenous grafts (AVGs) because AVFs had superior long-term patency, required fewer interventions to maintain patency, and were associated with lower costs of vascular access management. However, subsequent research has questioned the "Fistula First strategy" (placing an AVF whenever the vascular anatomy is suitable). First, AVF non-maturation is substantial (30-40%), and even higher among women, older patients and those with peripheral vascular disease.
View Article and Find Full Text PDF